Dexelvucitabine (C007B-348741)

Dexelvucitabine (Reverset; d-d4FC), a Cytidine ( HY-B0158 ) analog, is an orally active nucleoside reverse transcriptase inhibitor. Dexelvucitabine is a powerful agent against HIV-1-resistant viruses containing a thymidine analog and/or M184V mutation in the viral polymerase. Dexelvucitabine is a 2′-Deoxycytidine antiretroviral agentIn VivoDexelvucitabine (Reverset; d-d4FC; 33.3 mg/kg by i.v. or p.o.) has distribution and elimination half-lives (t 1/2α and t 1/2β , respectively) of 0.7 and 3.6 h in monkeys, respectively. The C max ranges from 21.1 to 47.5 μM. Dexelvucitabine has a favorable pharmacokinetic profile with a long half-life (4.71 and 10.75 h after administration by the intravenous [i.v.] and oral [p.o.] routes, respectively) in woodchucks. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:HIV-1. Specification: 0.99 Molecular Formula: C9H10FN3O3 Molecular Weight: 227.19 PubChem CID: 64973 Isomeric SMILES: C1=C[C@@H](O[C@@H]1CO)N2C=C(C(=NC2=O)N)F

UPC:

51361801

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

D650133-25mg

CAS:

134379-77-4

Product Size:

25mg